Table 2. .
Determination |
Control (9) |
Diabetic (10) |
Diabetic + Ilepatril (10) |
Thiobarbituric acid reactive substances, μg/mL | 0.78 ± 0.04 | 0.94 ± 0.04* | 0.92 ± 0.06 |
Triglycerides, mg/dL | 14 ± 1 | 130 ± 16* | 52 ± 7+ |
Free fatty acids, mmol/L | 0.06 ± 0.01 | 0.42 ± 0.06* | 0.46 ± 0.08* |
Cholesterol, mg/mL | 1.2 ± 0.1 | 4.3 ± 0.5* | 1.7 ± 0.2+ |
ACE activity, mU/mL | 34 ± 2 | 55 ± 6* | 17 ± 2*,+ |
Corneal sensitivity, cm | 5.97 ± 0.03 | 5.77 ± 0.07* | 6.00 ± 0.00+ |
Tear production, fiber length, mm | 22.3 ± 0.7 | 15.2 ± 0.8* | 17.5 ± 0.6* |
Cornea thickness, μm | 137 ± 10 | 126 ± 6 | 121 ± 6 |
Data are presented as the mean ± SEM. One unit of angiotensin converting enzyme activity is defined as the amount of enzyme required to release 1 μmol of hippuric acid per minute and per liter of serum at 37°C. *P < 0.05 compared to control, +P < 0.05, compared to diabetic. Parentheses indicate the number of experimental animals.